Onya Therapeutics
Onya Therapeutics is a biotech startup based in Wales, UK, focused on developing novel wound care therapies. Their mission is to reduce the use of antibiotics in wound care and combat antimicrobial resistance. They are dedicated to creating advanced wound healing technologies that improve patient outcomes and quality of life.
Industries
Nr. of Employees
small (1-50)
Products
Targeted controlled-release wound dressing for excess exudate
A patented patch-format dressing that delivers a known active compound locally to manage excess wound exudate, with the aim of accelerating healing and reducing dressing change frequency.
Controlled-release patch for high-risk acute wounds
A patch-formulation designed for acute traumatic wounds at high risk of infection, engineered for targeted sustained release and extended wear time.
Topical therapeutic for infected wounds (alternative to antibiotics)
A topically applied therapeutic intended to treat infected wounds using locally available active agents as an alternative to systemic antibiotics.
Targeted controlled-release wound dressing for excess exudate
A patented patch-format dressing that delivers a known active compound locally to manage excess wound exudate, with the aim of accelerating healing and reducing dressing change frequency.
Controlled-release patch for high-risk acute wounds
A patch-formulation designed for acute traumatic wounds at high risk of infection, engineered for targeted sustained release and extended wear time.
Topical therapeutic for infected wounds (alternative to antibiotics)
A topically applied therapeutic intended to treat infected wounds using locally available active agents as an alternative to systemic antibiotics.
Services
Collaborative R&D partnerships
Collaborative research and development projects with academic institutions and industry partners to advance wound care technologies.
Clinical advisory and trial design support
Provision of clinical expertise and advisory board input to inform clinical strategy, endpoint selection and trial design for wound care studies.
Programme management for clinical translation
Project and programme management services focused on translating laboratory technologies into scalable commercial products, including technical and regulatory coordination.
Collaborative R&D partnerships
Collaborative research and development projects with academic institutions and industry partners to advance wound care technologies.
Clinical advisory and trial design support
Provision of clinical expertise and advisory board input to inform clinical strategy, endpoint selection and trial design for wound care studies.
Programme management for clinical translation
Project and programme management services focused on translating laboratory technologies into scalable commercial products, including technical and regulatory coordination.
Expertise Areas
- Wound care therapeutics development
- Topical drug delivery and patch systems
- Antivirulence antimicrobial research
- Pre-clinical development and safety assessment
Key Technologies
- Controlled-release topical patch delivery
- Targeted local drug delivery for wounds
- Quorum sensing and virulence inhibition approaches
- Topical formulation engineering